9,11-linoleic acid has been researched along with troglitazone in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belton, O; de Gaetano, M; Fitzgerald, DJ; James, WG; McCarthy, C; McClelland, S; O'Gaora, P | 1 |
1 other study(ies) available for 9,11-linoleic acid and troglitazone
| Article | Year |
|---|---|
SorLA modulates atheroprotective properties of CLA by regulating monocyte migration.
Topics: Animals; Atherosclerosis; Cell Movement; Chemokine CCL2; Chromans; Humans; Linoleic Acids, Conjugated; Membrane Transport Proteins; Mice; Monocytes; PPAR gamma; Receptors, LDL; Receptors, Urokinase Plasminogen Activator; Thiazolidinediones; Troglitazone | 2010 |